COLUMN GROUP III-A, LP — SEC insider filings

SEC reporting owner CIK 1668085. 50 insider filings on record with FilingPulse; latest filed 2026-10-22.

Transaction summary — filings shown

Covers all 50 filings on record, filed 2020-08-17 to 2026-10-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Revolution Medicines, Inc. (RVMD)10% owner1—2 legs · 2,027,156 sh · $73,788,478—
Tenaya Therapeutics, Inc. (TNYA)10% owner118 legs · 49,313,559 sh · $64,556,62012 legs · 9,400,290 sh · $5,927,19910
NGM BIOPHARMACEUTICALS INC (NGM)10% owner2772 legs · 3,899,822 sh · $31,317,626—14
Surrozen, Inc./DE (SRZN)10% owner925 legs · 1,838,785 sh · $23,984,607—35
CONSTELLATION PHARMACEUTICALS INC (CNST)10% owner2—1 leg · 10,000 sh · $369,5032

Insider filings — COLUMN GROUP III-A, LP

FiledFormIssuerReported transactionsSource
2026-10-224Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter
Option exercise/expiry (X): 485,830 @ $11.60 · Option exercise/expiry (X): 548,653 @ $11.60 · Option exercise/expiry (X): 517,241 @ $11.60 · Option exercise/expiry (X): 728,745 (derivative) · Option exercise/expiry (X): 822,980 (derivative) · Option exercise/expiry (X): 775,861 (derivative) · +3 moreEDGAR
2026-02-264Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter
Sale (S): 309,228 @ $0.62 · Sale (S): 349,212 @ $0.62 · Sale (S): 1,649,281 @ $0.56 · Sale (S): 1,862,545 @ $0.56EDGAR
2026-02-244Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter
Sale (S): 245,965 @ $0.61 · Sale (S): 277,769 @ $0.61 · Sale (S): 143,709 @ $0.60 · Sale (S): 162,291 @ $0.60EDGAR
2026-02-124Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter
Sale (S): 161,422 @ $0.82 · Sale (S): 182,295 @ $0.82 · Sale (S): 1,905,115 @ $0.68 · Sale (S): 2,151,458 @ $0.68EDGAR
2026-01-204Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter
Purchase (P): 5,590 @ $19.89 · Purchase (P): 6,303 @ $19.89 · Purchase (P): 1,204 @ $20 · Purchase (P): 1,358 @ $20 · Purchase (P): 8,484 @ $19.60 · Purchase (P): 9,568 @ $19.60EDGAR
2026-01-154Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter
Purchase (P): 5,861 @ $19.80 · Purchase (P): 6,609 @ $19.80 · Purchase (P): 2,596 @ $19.99 · Purchase (P): 2,927 @ $19.99EDGAR
2026-01-084Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Svennilson Peter
Purchase (P): 7,097 @ $19.89 · Purchase (P): 8,003 @ $19.89EDGAR
2025-12-084Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 2,475 @ $17.35 · Purchase (P): 14,503 @ $19.54 · Purchase (P): 2,791 @ $17.35 · Purchase (P): 16,381 @ $19.54EDGAR
2025-11-174Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 148,150 @ $12.65 · Purchase (P): 167,307 @ $12.65EDGAR
2025-03-284Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 323,886 @ $11.60 · Purchase (P): 365,769 @ $11.60 · Purchase (P): 344,827 @ $11.60 · Code (H): 90,897 (derivative) · Purchase (P): 90,897 (derivative) · Code (H): 102,651 (derivative) · +15 moreEDGAR
2025-03-074Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 35,714,284 @ $0.70 · Purchase (P): 35,714,284 (derivative) · Purchase (P): 17,857,142 (derivative)EDGAR
2024-04-174/ASurrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP
Purchase (P): 90,897 @ $15.50 · Purchase (P): 102,651 @ $15.50EDGAR
2024-04-084NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 moreEDGAR
2024-04-084Surrozen, Inc./DE (SRZN)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP
Purchase (P): 90,897 @ $15.50 · Purchase (P): 102,651 @ $15.50 · Purchase (P): 90,897 (derivative) · Purchase (P): 102,651 (derivative) · Purchase (P): 98,870 (derivative) · Purchase (P): 111,656 (derivative) · +4 moreEDGAR
2024-02-144Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 2,222,222 @ $4.50EDGAR
2023-11-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 16,791 @ $0.71 · Purchase (P): 5,840 @ $0.62EDGAR
2023-03-144Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 6,779 @ $2.60EDGAR
2023-02-104Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 1,500,000 @ $2.60EDGAR
2023-02-014NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 7,542 @ $5.00 · Purchase (P): 176,730 @ $5.00EDGAR
2023-01-254NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 9,900 @ $5.00EDGAR
2023-01-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 37,639 @ $5.00 · Purchase (P): 500 @ $5.00EDGAR
2023-01-234Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 69,739 @ $2.50EDGAR
2023-01-194Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 49,463 @ $2.49 · Purchase (P): 135,688 @ $2.52EDGAR
2023-01-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 5,378 @ $4.95EDGAR
2023-01-124NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 100,070 @ $4.84 · Purchase (P): 209,000 @ $4.76EDGAR
2022-12-144NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 300 @ $4.98EDGAR
2022-11-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 35,997 @ $5.00 · Purchase (P): 4,330 @ $5.00EDGAR
2022-11-234Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC
Purchase (P): 9,615,384 @ $2.60EDGAR
2022-11-074NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 104,090 @ $4.99 · Purchase (P): 35,058 @ $4.72EDGAR
2022-10-314NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 76,877 @ $4.86EDGAR
2022-10-274NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP
Purchase (P): 51,046 @ $4.75 · Purchase (P): 72,774 @ $4.85EDGAR
2022-06-134NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 951,684 @ $13.50 · Purchase (P): 32,477 @ $13.50EDGAR
2022-06-064NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 33,071 @ $13.03 · Purchase (P): 1,129 @ $13.03EDGAR
2022-06-024NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 59,766 @ $13.47 · Purchase (P): 2,040 @ $13.47 · Purchase (P): 88,964 @ $13.45 · Purchase (P): 3,036 @ $13.45EDGAR
2022-05-314NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 19,534 @ $13.49 · Purchase (P): 667 @ $13.49 · Purchase (P): 2,621 @ $13.45 · Purchase (P): 89 @ $13.45EDGAR
2022-05-264NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 17,240 @ $13.37 · Purchase (P): 588 @ $13.37 · Purchase (P): 41,863 @ $13.43 · Purchase (P): 1,429 @ $13.43EDGAR
2022-05-234NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 19,984 @ $13.25 · Purchase (P): 682 @ $13.25 · Purchase (P): 18,406 @ $13.48 · Purchase (P): 628 @ $13.48EDGAR
2022-05-194NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 86,110 @ $13.42 · Purchase (P): 2,939 @ $13.42 · Purchase (P): 60,583 @ $13.20 · Purchase (P): 2,067 @ $13.20EDGAR
2022-05-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 125,096 · Purchase (P): 4,269 · Purchase (P): 32,072 @ $12.90 · Purchase (P): 1,094 @ $12.90EDGAR
2022-05-134NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 77,866 @ $11.23 · Purchase (P): 2,657 @ $11.23 · Purchase (P): 2,564 @ $11.85 · Purchase (P): 88 @ $11.85 · Purchase (P): 79,945 @ $11.62 · Purchase (P): 2,728 @ $11.62 · +2 moreEDGAR
2022-05-114NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 80,430 @ $10.79 · Purchase (P): 2,745 @ $10.79 · Purchase (P): 30,233 @ $11.36 · Purchase (P): 1,032 @ $11.36EDGAR
2022-01-264NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, Column Group IV, LP, Column Group IV-A, LP, Column Group IV GP, LP, TCG IV GP, LLC
Purchase (P): 241,750 · Purchase (P): 8,250 · Purchase (P): 579,910 · Purchase (P): 19,791EDGAR
2021-08-044Tenaya Therapeutics, Inc. (TNYA)
jointly with COLUMN GROUP III GP, LP, COLUMN GROUP III, LP
Conversion (C): 4,389,282 @ $0 · Conversion (C): 4,956,842 @ $0 · Conversion (C): 3,727,742 (derivative) · Conversion (C): 4,209,755 (derivative) · Conversion (C): 472,659 (derivative) · Conversion (C): 533,781 (derivative) · +2 moreEDGAR
2021-02-194CONSTELLATION PHARMACEUTICALS INC (CNST)
jointly with COLUMN GROUP L P, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, COLUMN GROUP GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim
Sale (S): 10,000 @ $36.95EDGAR
2020-12-164CONSTELLATION PHARMACEUTICALS INC (CNST)
jointly with COLUMN GROUP L P, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, COLUMN GROUP GP, LP, PONOI CAPITAL, LP, Ponoi Management, LLC, Ponoi Capital II, LP, Ponoi II Management, LLC, Kutzkey Tim
Option exercise/expiry (X): 30,107 @ $1.55 · Option exercise/expiry (X): 30,107 (derivative) @ $0EDGAR
2020-11-184Revolution Medicines, Inc. (RVMD)
jointly with COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, PONOI CAPITAL, LP, Ponoi Capital II, LP, Ponoi Management, LLC, Ponoi II Management, LLC, Kutzkey Tim, GOEDDEL DAVID V
Sale (S): 952,023 @ $36.40 · Sale (S): 1,075,133 @ $36.40EDGAR
2020-09-034NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, Svennilson Peter, GOEDDEL DAVID V
Purchase (P): 36,494 @ $17.64 · Purchase (P): 27,595 @ $17.67EDGAR
2020-08-314NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, GOEDDEL DAVID V, Svennilson Peter
Purchase (P): 36,359 @ $17.79 · Purchase (P): 26,135 @ $17.89EDGAR
2020-08-254NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, GOEDDEL DAVID V, Svennilson Peter
Purchase (P): 7,321 @ $17.97 · Purchase (P): 11,024 @ $17.96 · Purchase (P): 100 @ $18EDGAR
2020-08-174NGM BIOPHARMACEUTICALS INC (NGM)
jointly with COLUMN GROUP L P, COLUMN GROUP III, LP, COLUMN GROUP III GP, LP, GOEDDEL DAVID V, Svennilson Peter
Purchase (P): 19,895 @ $17.89 · Purchase (P): 37,993 @ $17.49 · Purchase (P): 6,425 @ $17.89EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1668085 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs